Streetbeat News

Price Targets

PSTV

HC Wainwright & Co. analyst Sean Lee maintains a 'Buy' rating on Plus Therapeutics (NASDAQ:PSTV) and raises the price target from $3.5 to $8.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:15 am

ZG

Stephens & Co. analyst John Campbell maintains an Overweight rating on Zillow Gr (NASDAQ:ZG) and raises the price target from $57 to $60.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 10:14 am

ARWR

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Arrowhead Pharma (NASDAQ:ARWR) and maintained a $90 price target.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:13 am

SLGG

HC Wainwright & Co. analyst Scott Buck has reinstated Super League Gaming (NASDAQ:SLGG) with a Buy rating and maintains a $2 price target.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:13 am

UUUU

HC Wainwright & Co. analyst Heiko Ihle has reiterated a 'Buy' rating on Energy Fuels (AMEX:UUUU) and maintained a price target of $9.75.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:12 am

MRUS

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Merus (NASDAQ:MRUS) and maintained a price target of $46.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:10 am

AVDL

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Avadel Pharmaceuticals (NASDAQ:AVDL) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:10 am

BMRN

Truist Securities analyst Robyn Karnauskas maintains a 'Buy' rating on Biomarin Pharmaceutical (NASDAQ:BMRN) and raises the price target from $125 to $140.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 10:10 am

ACCD

Needham analyst Ryan MacDonald has maintained a 'Buy' rating on Accolade (NASDAQ:ACCD) and raised the price target from $15 to $17.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:09 am

WBX

Chardan Capital analyst Brian Dobson has maintained a 'Buy' rating on Wallbox (NYSE:WBX) but lowered the price target from $12 to $11.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:08 am